Ultra-deep duplex sequencing reveals unique features of somatic evolution in the normal tissues of a family with Li-Fraumeni syndrome
Using ultra-deep duplex sequencing, this study reveals that the germline TP53 p.R181H variant in Li-Fraumeni syndrome reshapes baseline somatic mutation patterns and selection dynamics in normal tissues, characterized by increased mutagenesis, reduced positive selection for somatic TP53 mutations, and a distinct preference for mutations occurring on the wild-type chromosomal copy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Every person carries a set of instructions in their cells that act as a quality control system, checking for damage and stopping cells from growing when something is wrong. In some families, a specific error in these instructions is passed down from parent to child, meaning the quality control system is already weakened before a person is even born. This condition, known as Li-Fraumeni syndrome, makes carriers highly susceptible to developing many different types of cancer at a young age. While scientists have long studied the tumors that form in these individuals, the story of what happens inside the healthy tissues of their bodies before cancer ever appears has remained largely a mystery. Understanding how these cells change over time in a person who is not yet sick could reveal the very earliest steps of how cancer begins.
To uncover these hidden changes, researchers turned to a family carrying a specific inherited error in their quality control gene and compared them to a group of people without this error. They used a highly sensitive method to read the genetic code of cells, looking for tiny mistakes that accumulate over a lifetime. In blood samples, they found that people with the inherited error carried a higher number of random genetic mistakes across their genome compared to those without the error. Surprisingly, the usual pattern of natural selection within the blood was altered; the cells did not show the expected increase in specific mutations that typically help cells survive, even though one person in the group had received chemotherapy, which can complicate the picture. The study also observed that certain mutations in genes related to blood cell function were either favored or discouraged across the entire group, regardless of whether they carried the inherited error.
The researchers took this investigation much further by examining a single individual from the family who had passed away from esophageal cancer. They collected samples from twenty-two different healthy tissues and six cancerous sites found during the autopsy. This deep look revealed that tissues constantly exposed to the sun, such as skin, and tissues subject to chronic irritation, like the stomach and esophagus, carried significantly more genetic damage than other parts of the body. In nearly every tissue sample they examined, they found a specific, recurring mistake in the quality control gene, suggesting that this particular error is a common event in the life of these cells. Most importantly, when they looked at the timing of these events, they found that the new, damaging mutations in the quality control gene usually appeared on the copy of the gene that did not already carry the inherited error. This study shows how an inherited weakness reshapes the way normal cells accumulate changes and compete with one another long before a tumor forms, offering a clearer view of the quiet, early evolution that precedes cancer.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.